S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LPTX Leap Therapeutics Inc

3.0999

0.0399 (1.30%)

14 Jan 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics Inc News

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
Monday 6 January 2025 (1 week ago) • PR Newswire (US)

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Tuesday 26 November 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Leap Therapeutics Reports Third Quarter 2024 Financial Results
Wednesday 13 November 2024 (2 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 1 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 1 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 5 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 5 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 5 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 5 October 2024 (3 months ago) • Edgar (US Regulatory)

More Leap Therapeutics Inc News Articles

Global Partners

European Bank for Recons...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions